Concepedia

Sohan Dey

SD

2

Publications

53

Citations

2

H-Index

2022

Active since

Affiliations

Novo Nordisk (India)(Current)

Novo Nordisk (Denmark)

Sohan Dey is an author at Novo Nordisk (India) specializing in clinical trials, immunodeficiencies, and immunohematology.

Top concepts

Publications per year

2022–2025

2

Publications

2

Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study

Kirsten Dahl, Søren Toubro, Sohan Dey et al. · The Lancet · 2025 · 31 citations

The safety and efficacy of N8-GP (turoctocog alfa pegol) in previously untreated pediatric patients with hemophilia A

Christoph Male, Christoph Königs, Sohan Dey et al. · Blood Advances · 2022 · 22 citations · Full text

, , +18

Rows per page

1–2 of 2